Phase II study of tivozanib, an oral VEGFR inhibitor, in...

Journal of Neuro-Oncology 2017 / 2 Vol. 131; Iss. 3

Phase II study of tivozanib, an oral VEGFR inhibitor, in patients with recurrent glioblastoma

Kalpathy-Cramer, Jayashree, Chandra, Vyshak, Da, Xiao, Ou, Yangming, Emblem, Kyrre E., Muzikansky, Alona, Cai, Xuezhu, Douw, Linda, Evans, John G., Dietrich, Jorg, Chi, Andrew S., Wen, Patrick Y., Stu
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
131
Language:
english
Journal:
Journal of Neuro-Oncology
DOI:
10.1007/s11060-016-2332-5
Date:
February, 2017
File:
PDF, 475 KB
english, 2017
Conversion to is in progress
Conversion to is failed